Welcome to our dedicated page for EVOGENE LTD. news (Ticker: $EVGN), a resource for investors and traders seeking the latest updates and insights on EVOGENE LTD. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EVOGENE LTD.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EVOGENE LTD.'s position in the market.
Rhea-AI Summary
Lavie Bio Ltd., a subsidiary of Evogene Ltd., secures $2.5 million as the second-half advance payment under the licensing agreement with Corteva, completing a total $5 million advance payment. The agreement grants Corteva exclusive rights to develop and commercialize bio-fungicide products targeting fruit rots and powdery mildew. Lavie Bio will receive future milestone payments and royalties from Corteva's sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.07%
Tags
-
Rhea-AI Summary
Evogene Ltd. (EVGN) to release financial results for Q3 2023 on March 7th, 2024. Conference call scheduled for 9:00 AM ET. Company aims to revolutionize life-science product discovery and development. Replay and webcast details provided for investor access.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
-
Rhea-AI Summary
AgPlenus Ltd, a subsidiary of Evogene Ltd., appoints Dr. Dan Jacob Gelvan as CEO, bringing extensive experience in science and technology sectors. Dr. Gelvan's leadership aims to drive growth and innovation in sustainable crop protection products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
Rhea-AI Summary
AgPlenus Ltd., a subsidiary of Evogene Ltd., collaborates with Bayer AG to develop a sustainable herbicide using AI technology. The collaboration aims to address weed resistance challenges in agriculture by designing a novel Mode-of-Action herbicide targeting the APTH1 protein.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.37%
Tags
-
Rhea-AI Summary
Syngenta Crop Protection and Lavie Bio Ltd., a subsidiary of Evogene Ltd., announce a collaboration to develop new biological insecticidal solutions to combat global crop challenges caused by insects. The agreement combines Lavie Bio's technology platform with Syngenta's research and commercialization capabilities to address the $70 billion annual economic impact of insect damage on crops.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
-
Rhea-AI Summary
Evogene Ltd. (EVGN) and Verb Biotics LLC. have entered into a collaboration agreement to develop new strains of probiotic bacteria that produce highly sustainable quantities of microbial metabolites, aiming to improve human health and vitality. The probiotics market is expected to double and reach approximately $114 billion by 2031, creating significant opportunities for growth. The financial terms of the agreement are not disclosed. The collaboration combines Evogene's tech-engine MicroBoost AI with Verb Biotic's access to the genomes of various microbial strains, generating excellent synergy. The collaboration underscores Evogene's strategic commitment to leveraging AI tech-engines in new areas and opens doors for additional sectors in the life sciences industry to benefit from their powerful technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
News
Rhea-AI Summary
Biomica Ltd., a subsidiary of Evogene Ltd. (EVGN), announced that its CEO, Dr. Elran Haber, will participate in the 8th Annual Microbiome Movement Drug Development Summit Europe in Barcelona, Spain. The summit will focus on microbiome functionality, translation, clinical development, biomarker discovery, and manufacturing scale-up. Dr. Haber will join industry panel discussions and be available for one-on-one meetings at the conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.53%
Tags
-
News
Rhea-AI Summary
Biomica Ltd., a subsidiary of Evogene Ltd., has completed enrollment for its Phase I clinical trial evaluating the safety and tolerability of its microbiome-based immuno-oncology drug candidate, BMC128, in combination with immune checkpoint inhibitor immunotherapy for patients with NSCLC, melanoma, or RCC. The study, conducted in Israel, is on track with preliminary results, and the first data point readout is expected in H1 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.2%
Tags
-
Rhea-AI Summary
Biomica Ltd. (EVGN) to Participate in JP Morgan 42nd Annual Healthcare Week and Biotech Showcase Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
Rhea-AI Summary
Casterra Ag Ltd. (EVGN) announces the appointment of Mr. Yoash Zohar as the new CEO to lead the company's operational expansion, with a focus on increasing castor seed production capacity to support the bio-diesel industry's growing needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.93%
Tags
EVOGENE LTD.
Nasdaq:EVGN
EVGN Rankings
EVGN Stock Data
35.94M
46.63M
1.66%
8.91%
0.17%
Pesticide and Other Agricultural Chemical Manufacturing
Manufacturing
United States of America
Rehovot
About EVGN
evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch